Upload
atiafr
View
219
Download
0
Embed Size (px)
Citation preview
8/11/2019 Dengue Hemorragic Fever
1/93
Update on
Management of
PediatricDengue
YuliaIriani
8/11/2019 Dengue Hemorragic Fever
2/93
8/11/2019 Dengue Hemorragic Fever
3/93
Disease burden
Indonesia:
- Maor public healthproblem.
- eading cause ofhospitali&a! on and
death amongchildren.
- 0$perendemicit$ with all1 serot$pes circula!ng in
urban areas.
- preading to rural areas.
mailto:hospitaliza@onmailto:hospitaliza@onmailto:hospitaliza@onmailto:hospitaliza@onmailto:hospitaliza@onmailto:circula@ngmailto:circula@ngmailto:circula@ngmailto:circula@ngmailto:hospitaliza@onmailto:circula@ng8/11/2019 Dengue Hemorragic Fever
4/93
3auses of D04 Death
Dela$ed diagnosis
6PD prolonged shoc"
7PD 8uid o9erload b$ h$potonic
solu!ons :5( D/ ;/2 at M rate
8/11/2019 Dengue Hemorragic Fever
5/93
Prolonged shoc" grade
7=
>ithout proper treatment
+ 1
hours
o 0epa!c failure prognosis 5#(
sur9i9al o ? @enal failure
prognosis ,#( sur9i9al o ? A
organ
failure
prognosis
Miracle
+ ,#
hours
Death
mailto:Hepa@cmailto:Hepa@c8/11/2019 Dengue Hemorragic Fever
6/93
Coals of dengue
management
@ecogni&e dengue
infec!on at an
earl$
stage
Detect the earl$ onset of plasmalea"age
in
these pa!ents
and
Eppropriatel$ manage
deh$dra!on
and
h$po9olemia.
@educe
mortalit$
and
morbidit$
mailto:infec@onmailto:infec@onmailto:infec@onmailto:infec@onmailto:infec@onmailto:pa@entsmailto:pa@entsmailto:pa@entsmailto:pa@entsmailto:dehydra@onmailto:dehydra@onmailto:dehydra@onmailto:dehydra@onmailto:dehydra@onmailto:infec@onmailto:pa@entsmailto:dehydra@on8/11/2019 Dengue Hemorragic Fever
7/93
=irusF =ector and
Gransmission
8/11/2019 Dengue Hemorragic Fever
8/93
*thiological agent
8/11/2019 Dengue Hemorragic Fever
9/93
Aedes aegyp*
8/11/2019 Dengue Hemorragic Fever
10/93
Dengue transmission
8/11/2019 Dengue Hemorragic Fever
11/93
Disease
Pathogenesis
8/11/2019 Dengue Hemorragic Fever
12/93
3urrent 0$pothesis
D*;= tropism 3ells of the immune s$stem 6rgan patholog$ *ndothelial cells
=irus 9irulence
En!bod$HIDependent *nhancement
3omplement s$stem ac!9a!on Eutoimmunit$ 0ost gene!c factors 3rossHI@eac!9eGHI3ell response
mailto:An@body-mailto:An@body-mailto:An@body-mailto:An@body-mailto:ac@vamailto:ac@vamailto:ac@vamailto:ac@vamailto:ac@vamailto:ac@vamailto:ac@vamailto:gene@cmailto:gene@cmailto:gene@cmailto:gene@cmailto:Reac@vemailto:Reac@vemailto:Reac@vemailto:Reac@vemailto:An@body-mailto:ac@vamailto:gene@cmailto:Reac@ve8/11/2019 Dengue Hemorragic Fever
13/93
8/11/2019 Dengue Hemorragic Fever
14/93
Proposed model of heterologous immunit$ in secondar$ dengue 9irus infec!ons and its implica!ons for the
pathogenesis of dengue hemorrhagic fe9er. Primar$ D*;=HI2 infec!on and se%uen!al D*;=HI, and D*;=HI2 infec!onsare
compared
for
illustra!on
purposes.
Ghe
nai9e
G
cell
repertoire
:pale
colors06/GD@
2##'
SDengue is
one
disease
en!t$
with
diJerent clinical
presenta! ons and
osen with unpredictable clinical
e9olu!on
and
outcomeT
mailto:en@tymailto:en@tymailto:en@tymailto:en@tymailto:en@tymailto:presenta@onsmailto:presenta@onsmailto:presenta@onsmailto:presenta@onsmailto:presenta@onsmailto:evolu@onmailto:evolu@onmailto:evolu@onmailto:evolu@onmailto:evolu@onmailto:en@tymailto:presenta@onsmailto:evolu@onmailto:evolu@on8/11/2019 Dengue Hemorragic Fever
34/93
8/11/2019 Dengue Hemorragic Fever
35/93
3@7G*@7E 46@ D*;CU* U>E@;7;C 7C;
ProbableDengue
- li9e in /tra9el to dengueendemic
area.4e9er and 2 of the followingcriteria- ;auseaF 9omi!ng
- @ash- Eches and pains- Gourni%uet test posi!9e
- eu"openia- En$ warning signaborator$HIconLrmed dengue :important when nosign of plasma lea"age<
>arning ignsV
- Ebdominal pain ortenderness- Persistent 9omi!ng
- 3linical 8uid accumula!on- Mucosal bleed- etharg$F restlessness
- i9er enlargment +2 cm
- aborator$ increase in03G concurrent withrapid decrease in platelet
count
V:re%uiring strict obser9a!onand
medicalinter9en!on
8/11/2019 Dengue Hemorragic Fever
36/93
aborator$HIconLrmed
dengue
:important when no sign of plasma lea"age<
8/11/2019 Dengue Hemorragic Fever
37/93
3@7G*@7E 46@ *=*@*
D*;CU*
e9ere
plasmalea"ageleading
to
- hoc" :D06 ,''
>06 *E@6
2#,,
mailto:De%EF%AC%81ni@onmailto:De%EF%AC%81ni@onmailto:De%EF%AC%81ni@onmailto:De%EF%AC%81ni@onmailto:De%EF%AC%81ni@onmailto:De%EF%AC%81ni@on8/11/2019 Dengue Hemorragic Fever
40/93
3linical 3ase DeLni!on
Probable Dengue4e9er
3onLrmed Dengue4e9er
- 4e9er of 2 to da$sdura!onF with two ormore of the following
- 0eadacheF retroorbitalpainF m$algiaF arthralgiaF rashFhemorrhagic
manifesta! onsFleu"openiaF andsuppor!9e serolog$ oroccurrence at the sameloca!on and !me asother conLrmed cases
ofdengue.
mailto:De%EF%AC%81ni@onmailto:De%EF%AC%81ni@onmailto:De%EF%AC%81ni@onmailto:De%EF%AC%81ni@onmailto:dura@onmailto:dura@onmailto:dura@onmailto:dura@onmailto:dura@onmailto:manifesta@onsmailto:manifesta@onsmailto:manifesta@onsmailto:manifesta@onsmailto:suppor@vemailto:suppor@vemailto:suppor@vemailto:suppor@vemailto:suppor@vemailto:loca@onmailto:loca@onmailto:loca@onmailto:loca@onmailto:loca@onmailto:De%EF%AC%81ni@onmailto:dura@onmailto:dura@onmailto:manifesta@onsmailto:manifesta@onsmailto:suppor@vemailto:suppor@vemailto:loca@onmailto:loca@on8/11/2019 Dengue Hemorragic Fever
41/93
8/11/2019 Dengue Hemorragic Fever
42/93
8/11/2019 Dengue Hemorragic Fever
43/93
-Probable case and at least one of thefollowing
- 7sola!on of dengue 9irus from serumF34 orautops$ samples.
- 4ourfold or greater increase inserum 7gC :b$ 07 test
8/11/2019 Dengue Hemorragic Fever
44/93
3linical 3ase DeLni!on
mailto:De%EF%AC%81ni@onmailto:De%EF%AC%81ni@onmailto:De%EF%AC%81ni@onmailto:De%EF%AC%81ni@onmailto:De%EF%AC%81ni@on8/11/2019 Dengue Hemorragic Fever
45/93
>06 Crading of D04
8/11/2019 Dengue Hemorragic Fever
46/93
8/11/2019 Dengue Hemorragic Fever
47/93
3linical Management ofD04
8/11/2019 Dengue Hemorragic Fever
48/93
Principle of D04
Management Primar$ abnormali!es
in
D04
=asculopath$
Ghromboc$topeniaGhrombopath$
3oagulopath$ e9ere D73
mailto:abnormali@esmailto:abnormali@esmailto:abnormali@esmailto:abnormali@esmailto:abnormali@es8/11/2019 Dengue Hemorragic Fever
49/93
trateg$ of D04
Management uppor!9e therap$
Drug as
indicated
Plasma lea"age olume replacement 0ow to choose 8uid solu!on
25( need colloid
3linical course of D04 unpredictable monitoring
*arl$ detec!on and prompt treatment of
circulator$ disturbance clinicall$ Z P3=
bleeding manifesta! on clinicall$ and lab
mailto:Suppor@vemailto:Suppor@vemailto:Suppor@vemailto:solu@onmailto:solu@onmailto:solu@onmailto:solu@onmailto:detec@onmailto:detec@onmailto:detec@onmailto:detec@onmailto:manifesta@onmailto:manifesta@onmailto:manifesta@onmailto:manifesta@onmailto:Suppor@vemailto:solu@onmailto:detec@onmailto:manifesta@on8/11/2019 Dengue Hemorragic Fever
50/93
8/11/2019 Dengue Hemorragic Fever
51/93
6utpa!ent management ofpa!ents
withdengue
-arly
dengue Q#( of pa!ents ma"e the Lrst 9isit to amedical
doctor within the Lrst 2 da$s of fe9er
followHIup card diagnosis of
suspected
dengueF
serial
fullHIbloodHIcount results :to includeF at leastFhaematocrit
[er$throc$te
9olume
frac!on\